Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
EPA Approval of Enlist Duo Pesticide Violates Federal Law, Petition Claims April 19, 2018 Irvin Jackson Add Your CommentsEnvironmentalists and farmers petitioned federal regulators last week, seeking to reverse the approval of Enlist Duo, an herbicide that combines two active ingredients that critics say become more toxic when mixed together.ย The National Family Farm Coalition, the Center for Biological Diversity, the Natural Resources Defense Council and several other groups filed a petition (PDF) against the U.S. Environmental Protection Agency (EPA) and it’s commissioner Scott Pruitt on April 11, challenging the EPA’s expanded approval of Enlist Duo, a Dow pesticide that combines glyphosate, the active ingredient in Roundup, and 2,4- dichlorophenoxyacetic acid (2,4-D).Early last year, the EPA expanded approval of Enlist Duo in 34 states, for use on corn, cotton and soybean crops that have been genetically modified to withstand the pesticide. However, the petition, filed in the U.S. Court of Appeals for the Ninth Circuit, claims that the EPA failed in its mission to protect the environment, farms, public health and endangered species.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe approval came despite a 2015 EPA review, which found that Dow made claims of a โsynergisticโ effect between glyphosate and 2,4-D, which could make the two chemicals more toxic. The information was discovered in patent documents, but the EPA claims Dow never informed the agency that the two could become more powerful, and potentially more dangerous, when combined.The EPA indicates that it contacted Dow after discovering the synergism claims, and warned the company that this would assess how the regulators factored the potential impacts to non-target organisms. Dow responded with more data, which the EPA is still reviewing. However, the preliminary findings led EPA reviewers to conclude that a 30-foot buffer it required around application areas for Enlist Duo may be insufficient.Despite those concerns, the EPA granted expanded approval of the herbicide after the new administration came into office in early 2017.“EPA has put human health, neighboring crops, and the survival and recovery of hundreds of endangered species at risk by recklessly putting a potent and toxic pesticide on the market without the data or expert review the law requires,” Paul Achitoff, an attorney with Earthjustice said in a press release. “We, and the law, demand much more from the agency created to protect our health and environment than bowing to chemical industry pressure.”Glyphosate, the active ingredient most known for its use in Monsantoโs weed killer Roundup, wasย deemed to be a probably carcinogenย in March by the International Agency for Research on Cancer (IARC), an arm of the World Health Organization. The designation has led some countries to ban Roundup and other glyphosate-based pesticides.Monsanto now faces hundreds of Roundup lawsuits by agricultural workers who say they have been diagnosed with non-Hodgkin’s lymphoma due to long-term exposure to glyphosate.The chemical 2,4-D was used in Agent Orange, a defoliant during the Vietnam War, which has been linked to a number of illnesses afflicting veterans of the war.The petition calls for the appeals court to vacate the EPA’s approval, saying that the agency violated both the Endangered Species Act and the Federal Insecticide, Fungicide, and Rodenticide Act. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Chemicals, Dow, Enlist Duo, Glyphosate, Herbicide, RoundupMore Roundup Lawsuit Stories Judge Grants Preliminary Approval to Roundup Lawsuit Settlement Plan March 5, 2026 $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026 Roundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge February 9, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (Posted: yesterday)The first Bard PowerPort lawsuit bellwether trial commences next week involving claims that a man suffered a severe infection due to the port catheter’s allegedly defective design.MORE ABOUT: BARD POWERPORT LAWSUITJudge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026)Port-a-Cath Lawsuit Alleges Power P.A.C. Break Down Resulted in Serious Port Catheter Infection (03/31/2026)Final Pretrial Conference in Bard PowerPort Lawsuit To Be Held April 9 (03/27/2026) Hearings on Evidence That Depo-Provera Causes Meningioma Brain Tumors Set for Late June 2026 (Posted: 2 days ago)A federal judge has scheduled general causation hearings for Depo-Provera brain tumor lawsuits for June 24 through 26.MORE ABOUT: DEPO-PROVERA LAWSUITHigh-Risk Brain Tumor From Depo-Provera Requires Frequent Monitoring, Lawsuit Claims (04/06/2026)Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (03/25/2026)Depo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026) WaveWriter Alpha Lawsuit Claims Defective Spinal Cord Stimulator Caused Pain and Surgical Removal (Posted: 3 days ago)A Louisiana man’s Boston Scientific WaveWriter Alpha SCS lawsuit claims the implant failed to provide the promised pain relief and, in fact, made things worse before it needed to be surgically removed.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Neuromodulation Lawsuit Claims Spinal Cord Stimulator Exacerbated Chronic Pain (04/08/2026)Medtronic SCS Lawsuit Alleges Intellis LT Neurostimulator Caused Worsening Pain (04/03/2026)Nevro Spinal Cord Stimulator Lawsuits Filed Over Device Malfunction, Failure (03/30/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026
Roundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge February 9, 2026
Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (Posted: yesterday)The first Bard PowerPort lawsuit bellwether trial commences next week involving claims that a man suffered a severe infection due to the port catheter’s allegedly defective design.MORE ABOUT: BARD POWERPORT LAWSUITJudge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026)Port-a-Cath Lawsuit Alleges Power P.A.C. Break Down Resulted in Serious Port Catheter Infection (03/31/2026)Final Pretrial Conference in Bard PowerPort Lawsuit To Be Held April 9 (03/27/2026)
Hearings on Evidence That Depo-Provera Causes Meningioma Brain Tumors Set for Late June 2026 (Posted: 2 days ago)A federal judge has scheduled general causation hearings for Depo-Provera brain tumor lawsuits for June 24 through 26.MORE ABOUT: DEPO-PROVERA LAWSUITHigh-Risk Brain Tumor From Depo-Provera Requires Frequent Monitoring, Lawsuit Claims (04/06/2026)Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (03/25/2026)Depo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026)
WaveWriter Alpha Lawsuit Claims Defective Spinal Cord Stimulator Caused Pain and Surgical Removal (Posted: 3 days ago)A Louisiana man’s Boston Scientific WaveWriter Alpha SCS lawsuit claims the implant failed to provide the promised pain relief and, in fact, made things worse before it needed to be surgically removed.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Neuromodulation Lawsuit Claims Spinal Cord Stimulator Exacerbated Chronic Pain (04/08/2026)Medtronic SCS Lawsuit Alleges Intellis LT Neurostimulator Caused Worsening Pain (04/03/2026)Nevro Spinal Cord Stimulator Lawsuits Filed Over Device Malfunction, Failure (03/30/2026)